Year: 2018
Type: article
Abstract: Heart failure remains a major public-health problem with an increase in the number of patients worsening from this disease. Despite current medical therapy, the condition still has a poor prognosis. Heart failure is complex but mitochondrial dysfunction seems to be an important target to improve cardiac function directly. Our goal was to analyze the effects of MitoQ (100 µM in drinking water) on the development and progression of heart failure induced by pressure overload after 14 weeks. The main findings are that pressure overload-induced heart failure in rats decreased cardiac function in vivo that was not altered by MitoQ. However, we observed a reduction in right ventricular hypertrophy and lung congestion in heart failure animals treated with MitoQ. Heart failure also decreased total mitochondrial protein content, mitochondrial membrane potential in the intermyofibrillar mitochondria. MitoQ restored membrane potential in IFM but did not restore mitochondrial protein content. These alterations are associated with the impairment of basal and stimulated mitochondrial respiration in IFM and SSM induced by heart failure. Moreover, MitoQ restored mitochondrial respiration in heart failure induced by pressure overload. We also detected higher levels of hydrogen peroxide production in heart failure and MitoQ restored the increase in ROS production. MitoQ was also able to improve mitochondrial calcium retention capacity, mainly in the SSM whereas in the IFM we observed a small alteration. In summary, MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload, by decreasing hydrogen peroxide formation, improving mitochondrial respiration and improving mPTP opening.
Authors: Rogério Faustino Ribeiro Junior, Erinne Rose Dabkowski, Kadambari Chandra Shekar, Kelly A. O´Connell, Peter A. Hecker, Michael P. Murphy
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: MitoQ, mitochondrial dysfunction, heart failure, pressure overload, mitochondrial respiration, mitochondrial membrane potential, interfibrillar mitochondria, hydrogen peroxide, reactive oxygen species, mitochondrial calcium retention capacity, mitochondrial permeability transition pore, right ventricular hypertrophy, pulmonary congestion, mitochondrial protein content
Open Access status: hybrid
Estimated APC paid: $4,240
Awards: Docosahexaenoic Acid for Treatment of Heart Failure, Mitochondrial oxidative damage and human diseases, Cardiac Energy Metabolism in Heart Failure, Training Grant in Cardiac and Vascular Cell Biology, G4602585086, Exploring mitochondrial metabolism in health and disease using targeted biological chemistry., G476691100, Exploring mitochondrial metabolism in health and disease using targeted biological chemistry., G6257701723, G6842993084, G6868616705
OpenAlex ID: W2791224543
